• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

(3-Aminophenyl)(azepan-1-yl)methanone (CAS No. 401646-91-1): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

(3-Aminophenyl)(azepan-1-yl)methanone (CAS No. 401646-91-1) is a compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential therapeutic applications. This article provides a comprehensive overview of the compound, including its chemical structure, physical properties, and recent research findings.

Chemical Structure and Synthesis: (3-Aminophenyl)(azepan-1-yl)methanone is an amide derivative characterized by a benzene ring substituted with an amino group at the 3-position and an azepane ring attached via a carbonyl group. The molecular formula of this compound is C₁₃H₁₇NO₂, with a molecular weight of approximately 223.28 g/mol. The synthesis of (3-Aminophenyl)(azepan-1-yl)methanone typically involves the reaction of 3-aminobenzoyl chloride with azepane in the presence of a base such as triethylamine or pyridine.

Physical Properties: (3-Aminophenyl)(azepan-1-yl)methanone is a white crystalline solid at room temperature. It is sparingly soluble in water but exhibits good solubility in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO). The compound has a melting point ranging from 85 to 87°C and a boiling point that exceeds 300°C under standard atmospheric pressure. Its logP value, which indicates its lipophilicity, is approximately 2.5, suggesting that it can readily partition between lipid and aqueous phases.

Spectroscopic Data: The spectroscopic properties of (3-Aminophenyl)(azepan-1-yl)methanone have been extensively studied to aid in its identification and characterization. In infrared (IR) spectroscopy, the compound shows characteristic absorption bands at around 3300 cm^-1 (N-H stretch), 1650 cm^-1 (C=O stretch), and 750 cm^-1 (C-H out-of-plane bend). Nuclear magnetic resonance (NMR) spectroscopy reveals distinct signals for the aromatic protons at around 7.0 ppm, the methylene protons adjacent to the carbonyl group at around 4.0 ppm, and the azepane ring protons at around 2.5 ppm.

Biological Activity: Recent research has focused on the biological activity of (3-Aminophenyl)(azepan-1-yl)methanone, particularly its potential as a therapeutic agent. Studies have shown that this compound exhibits significant activity against various biological targets, including enzymes and receptors involved in neurological disorders and cancer. For instance, it has been reported to inhibit monoamine oxidase (MAO) enzymes, which are implicated in mood disorders such as depression and anxiety. Additionally, (3-Aminophenyl)(azepan-1-yl)methanone has demonstrated antiproliferative effects on cancer cell lines, suggesting its potential as an anticancer agent.

Mechanism of Action: The mechanism by which (3-Aminophenyl)(azepan-1-yl)methanone exerts its biological effects is not yet fully understood but is believed to involve multiple pathways. One proposed mechanism is the inhibition of MAO enzymes, which leads to increased levels of monoamines such as serotonin and norepinephrine in the brain. This can result in improved mood and reduced anxiety symptoms. Another potential mechanism involves the modulation of ion channels or receptors on cancer cells, leading to cell cycle arrest or apoptosis.

Clinical Applications: While still in the early stages of development, (3-Aminophenyl)(azepan-1-yl)methanone shows promise for various clinical applications. Its MAO-inhibiting properties make it a candidate for treating mood disorders, while its antiproliferative effects suggest potential use in cancer therapy. Preclinical studies have demonstrated its efficacy in animal models of depression and cancer, paving the way for further clinical trials.

Toxicity and Safety: The safety profile of (3-Aminophenyl)(azepan-1-yl)methanone is an important consideration for its potential therapeutic use. Initial toxicity studies have shown that the compound is well-tolerated at therapeutic doses with minimal side effects. However, more extensive safety evaluations are necessary to fully assess its long-term effects and potential interactions with other medications.

FUTURE DIRECTIONS: The ongoing research on (3-Aminophenyl)(azepan-1-yl)methanone aims to elucidate its pharmacological properties further and optimize its therapeutic potential. Future studies will likely focus on structure-activity relationship (SAR) analysis to identify more potent analogs with improved selectivity and reduced side effects. Additionally, clinical trials will be essential to validate its efficacy and safety in human subjects.

In conclusion, (3-Aminophenyl)(azepan-1-yl)methanone (CAS No. 401646-91-1) is a promising compound with diverse biological activities that warrant further investigation. Its unique chemical structure and favorable pharmacological profile make it an attractive candidate for drug development in areas such as neurology and oncology.

• 56302-41-1((4-aminophenyl)-pyrrolidin-1-yl-methanone)
• 42837-37-6(4-(piperidine-1-carbonyl)aniline)
• 79868-19-2(4-amino-N,N-dipropylbenzamide)
• 915908-51-9((3-Aminophenyl)(4-methylpiperidin-1-yl)methanone)
• 17243-02-6(Benzamide, N,N'-1,6-hexanediylbis[3-amino-)
• 675112-76-2(3-Amino-N-cyclohexyl-N-methylbenzamide)
• 68269-83-0(3-Amino-N,N-diethylbenzamide)
• 5157-66-4(4-(azepane-1-carbonyl)aniline)
• 77201-13-9((3-Aminophenyl)-1-piperidinyl-methanone)
• 160647-74-5((3-Aminophenyl)(pyrrolidin-1-yl)methanone)